Literature DB >> 27514282

Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism.

Ai Tamura1, Koshiro Nishimoto2, Tsugio Seki3, Yoko Matsuzawa1, Jun Saito1, Masao Omura1, Celso E Gomez-Sanchez4, Kohzoh Makita5, Seishi Matsui6, Nobukazu Moriya6, Atsushi Inoue7, Maki Nagata7, Hironobu Sasano8, Yasuhiro Nakamura8, Yuto Yamazaki8, Yasuaki Kabe9, Kuniaki Mukai10, Takeo Kosaka11, Mototsugu Oya11, Sachiko Suematsu1, Tetsuo Nishikawa12.   

Abstract

We report a case of non-familial juvenile primary aldosteronism (PA). Super-selective adrenal venous sampling identified less aldosterone production in the right inferior adrenal segment than others. Bilateral adrenalectomy sparing the segment normalized blood pressure and improved PA. Both adrenals had similar histologies, consisting of a normal adrenal cortex and aldosterone synthase-positive hyperplasia/adenoma. An aldosterone-driving KCNJ5 mutation was detected in the lesions, but not in the histologically normal cortex. After taking into account that the two adrenal glands displayed a similar histological profile, as well as the fact that hyperplastic lesions in both glands exhibited a common KCNJ5 mutation, we conclude that the specific mutation may have occurred at an adrenal precursor mesodermal cell, at an early stage of development; its daughter cells were mixed with non-mutant cells and dispersed into both adrenal glands, resulting into a form of the condition known as genetic mosaicism.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetic mosaicism; Juvenile; KCNJ5; Primary aldosteronism

Mesh:

Substances:

Year:  2016        PMID: 27514282      PMCID: PMC5482904          DOI: 10.1016/j.mce.2016.07.031

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  20 in total

Review 1.  Acute and chronic regulation of aldosterone production.

Authors:  Namita G Hattangady; Lawrence O Olala; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-08-04       Impact factor: 4.102

2.  Adrenocortical zonation in humans under normal and pathological conditions.

Authors:  Koshiro Nishimoto; Ken Nakagawa; Dan Li; Takeo Kosaka; Mototsugu Oya; Shuji Mikami; Hirotaka Shibata; Hiroshi Itoh; Fumiko Mitani; Takeshi Yamazaki; Tadashi Ogishima; Makoto Suematsu; Kuniaki Mukai
Journal:  J Clin Endocrinol Metab       Date:  2010-03-03       Impact factor: 5.958

3.  Intra-adrenal Aldosterone Secretion: Segmental Adrenal Venous Sampling for Localization.

Authors:  Nozomi Satani; Hideki Ota; Kazumasa Seiji; Ryo Morimoto; Masataka Kudo; Yoshitsugu Iwakura; Yoshikiyo Ono; Masahiro Nezu; Kei Omata; Sadayoshi Ito; Fumitoshi Satoh; Kei Takase
Journal:  Radiology       Date:  2015-07-06       Impact factor: 11.105

4.  Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.

Authors:  Tetsuo Nishikawa; Masao Omura; Fumitoshi Satoh; Hirotaka Shibata; Katsutoshi Takahashi; Naohisa Tamura; Akiyo Tanabe
Journal:  Endocr J       Date:  2011-08-09       Impact factor: 2.349

5.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

6.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

7.  Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells.

Authors:  Bethany D Freedman; Petra Bukovac Kempna; Diana L Carlone; Manasvi Shah; Nick A Guagliardo; Paula Q Barrett; Celso E Gomez-Sanchez; Joseph A Majzoub; David T Breault
Journal:  Dev Cell       Date:  2013-09-12       Impact factor: 12.270

8.  Fetal adrenal capsular cells serve as progenitor cells for steroidogenic and stromal adrenocortical cell lineages in M. musculus.

Authors:  Michelle A Wood; Asha Acharya; Isabella Finco; Jessica M Swonger; Marlee J Elston; Michelle D Tallquist; Gary D Hammer
Journal:  Development       Date:  2013-10-16       Impact factor: 6.868

9.  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

Authors:  Elena A B Azizan; Hanne Poulsen; Petronel Tuluc; Junhua Zhou; Michael V Clausen; Andreas Lieb; Carmela Maniero; Sumedha Garg; Elena G Bochukova; Wanfeng Zhao; Lalarukh Haris Shaikh; Cheryl A Brighton; Ada E D Teo; Anthony P Davenport; Tanja Dekkers; Bas Tops; Benno Küsters; Jiri Ceral; Giles S H Yeo; Sudeshna Guha Neogi; Ian McFarlane; Nitzan Rosenfeld; Francesco Marass; James Hadfield; Wojciech Margas; Kanchan Chaggar; Miroslav Solar; Jaap Deinum; Annette C Dolphin; I Sadaf Farooqi; Joerg Striessnig; Poul Nissen; Morris J Brown
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

10.  A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery.

Authors:  R Morimoto; N Satani; Y Iwakura; Y Ono; M Kudo; M Nezu; K Omata; Y Tezuka; K Seiji; H Ota; Y Kawasaki; S Ishidoya; Y Nakamura; Y Arai; K Takase; H Sasano; S Ito; F Satoh
Journal:  J Hum Hypertens       Date:  2015-11-05       Impact factor: 3.012

View more
  18 in total

1.  Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity.

Authors:  Taiki Hayashi; Zhen Zhang; Ghaith Al-Eyd; Atsushi Sasaki; Masanori Yasuda; Masafumi Oyama; Celso E Gomez-Sanchez; Hirotaka Asakura; Tsugio Seki; Kuniaki Mukai; Koshiro Nishimoto
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-08       Impact factor: 4.292

2.  Genetics of aldosterone-producing adenomas with pathogenic KCNJ5 variants.

Authors:  Antonio M Lerario; Kazutaka Nanba; Amy R Blinder; Sachiko Suematsu; Masao Omura; Tetsuo Nishikawa; Thomas J Giordano; William E Rainey; Tobias Else
Journal:  Endocr Relat Cancer       Date:  2019-02-01       Impact factor: 5.678

3.  Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma.

Authors:  Ute I Scholl; Laura Abriola; Chengbiao Zhang; Esther N Reimer; Mark Plummer; Barbara I Kazmierczak; Junhui Zhang; Denton Hoyer; Jane S Merkel; Wenhui Wang; Richard P Lifton
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

Review 4.  Genetic Alterations in Benign Adrenal Tumors.

Authors:  Georgia Pitsava; Constantine A Stratakis
Journal:  Biomedicines       Date:  2022-04-30

Review 5.  Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Koshiro Nishimoto
Journal:  Horm Metab Res       Date:  2020-04-14       Impact factor: 2.936

Review 6.  Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.

Authors:  Koshiro Nishimoto; Minae Koga; Tsugio Seki; Kenji Oki; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Mitsuhide Naruse; Tomokazu Sakaguchi; Shinya Morita; Takeo Kosaka; Mototsugu Oya; Tadashi Ogishima; Masanori Yasuda; Makoto Suematsu; Yasuaki Kabe; Masao Omura; Tetsuo Nishikawa; Kuniaki Mukai
Journal:  Mol Cell Endocrinol       Date:  2016-10-14       Impact factor: 4.102

Review 7.  The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

8.  Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.

Authors:  Christina Tatsi; Andrea G Maria; Cole Malloy; Lin Lin; Edra London; Nick Settas; Chelsi Flippo; Meg Keil; Fady Hannah-Shmouni; Dax A Hoffman; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

9.  Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia.

Authors:  Andrea G Maria; Mari Suzuki; Annabel Berthon; Crystal Kamilaris; Andrew Demidowich; Justin Lack; Mihail Zilbermint; Fady Hannah-Shmouni; Fabio R Faucz; Constantine A Stratakis
Journal:  Am J Hypertens       Date:  2020-02-22       Impact factor: 3.080

10.  A Novel Method: Super-selective Adrenal Venous Sampling.

Authors:  Kohzoh Makita; Koshiro Nishimoto; Kanako Kiriyama-Kitamoto; Shigehiro Karashima; Tsugio Seki; Masanori Yasuda; Seishi Matsui; Masao Omura; Tetsuo Nishikawa
Journal:  J Vis Exp       Date:  2017-09-15       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.